<DOC>
	<DOCNO>NCT01995240</DOCNO>
	<brief_summary>Novel predictive marker need determine treatment efficacy pancreatic cancer early stage . Preferably , marker could determine non-invasively provide insight biology pancreatic cancer . Several MR technique serve purpose . However , optimalisation technique need reproducibility assess .</brief_summary>
	<brief_title>Functional Magnetic Resonance Imaging Pancreatic Cancer : Feasibility Reproducibility Study</brief_title>
	<detailed_description>Background study : Novel predictive marker need determine treatment efficacy pancreatic cancer early stage . Preferably , marker could determine non-invasively provide insight biology pancreatic cancer . Several MR technique serve purpose . However , optimalisation technique need reproducibility assess . Objective study : To optimize DCE-MRI , T2* MRI DWI pancreatic cancer 3T investigate reproducibility . Study design : In first part study , patient pancreatic cancer undergo MR measurement protocol 3T , optimize MR technique ( DCE-MRI , T2* MRI DWI ) . In second part study , assess reproducibility patient undergo MR measurement protocol twice within one week start treatment .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<criteria>Patients pancreatic tumor , histological cytological proof adenocarcinoma high suspicion CT imaging . Any tumor size â‰¥ 1cm WHOperformance score 02 Written informed consent Any psychological , familial , sociological geographical condition potentially hamper adequate inform consent compliance study protocol . Contraindications MR scanning , include patient pacemaker , cochlear implant neurostimulator ; patient nonMR compatible metallic implant eye , spine , thorax abdomen ; aneurysm clip brain ; patient severe claustrophobia . Renal failure ( GFR &lt; 30 ml/min ) hamper safe administration Gadolinium contain MR contrast agent . For reproducibility part protocol : surgery , radiation and/or chemotherapy foreseen within timeframe need MRI scanning .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>pancreatic cancer</keyword>
	<keyword>MRI</keyword>
	<keyword>reproducibility</keyword>
	<keyword>optimalization</keyword>
</DOC>